Important Information

Disclaimer

Effective date: August 9, 2026

This website is provided for general informational purposes only. It is not medical advice, investment advice, an offer to sell securities, or a solicitation of investment.

Scientific and medical information

Content on this website describes Exonics' research focus, technology concepts, and development plans. It should not be used to diagnose, treat, cure, or prevent any disease, and it should not replace advice from qualified healthcare professionals.

Development-stage technology

References to Nova Morpheus, NV-Trinity, remyelination, blood-brain barrier delivery, blood-CSF barrier delivery, and related mechanisms describe technologies under development. Any product, platform, or research program mentioned may be subject to scientific, technical, regulatory, manufacturing, and commercial risk.

No patient claims

Nothing on this website should be interpreted as a claim that an Exonics product is approved, commercially available, clinically validated, or suitable for any individual patient.

Forward-looking statements

This website may include statements about expected development paths, collaborations, technology potential, or future plans. These statements are based on current assumptions and may change as research, validation, partnerships, and regulatory considerations evolve.

External links

Links to third-party websites are provided for convenience. Exonics does not control and is not responsible for the content, security, or privacy practices of third-party websites.